CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...
Phase 3
Orlando, Florida, United States and 107 other locations
This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofat...
Phase 4
Orlando, Florida, United States and 32 other locations
Open-label study to evaluate the effectiveness of treatment with ofatumumab in subjects transitioning from any fumarate-based RMS approved therapy or...
Phase 3
Maitland, Florida, United States and 122 other locations
This study will evaluate the impact of ofatumumab in Relapsing Remitting Multiple Sclerosis (RRMS) participants that are very early...
Phase 4
Orlando, Florida, United States and 35 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Orlando, Florida, United States and 208 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Orlando, Florida, United States and 225 other locations
This is a randomized, double-blind study of PIPE-307 or placebo in subjects with relapsing-remitting multiple sclerosis. Subjects w...
Phase 2
Port Orange, Florida, United States and 24 other locations
The main purpose of this study is to evaluate the safety and efficacy of LY3541860 in adult participants with multiple sclerosis th...
Phase 2
Winter Park, Florida, United States and 40 other locations
in male and female participants with relapsing forms of multiple sclerosis (aged 18 to 55 years at the time of enrollment). People ...
Phase 3
Maitland, Florida, United States and 34 other locations
The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the dis...
Phase 3
Maitland, Florida, United States and 30 other locations
Clinical trials
Research sites
Resources
Legal